Results 21 to 30 of about 18,836 (198)
Posaconazole and voriconazole are commonly used for preventing invasive fungal disease (IFD), but few studies compared posaconazole with voriconazole for primary antifungal prophylaxis (PAP) in pediatric acute leukemia.
Songji Tu +5 more
doaj +1 more source
Introduction: Posaconazole is a widely used antifungal drug, and its accurate quantification is essential for quality control and assessment of its pharmaceutical products.
Srinivas Hebbar +5 more
doaj +1 more source
Purpose: To assess and compare the efficacy and safety of posaconazole with fluconazole for the prevention of invasive fungal infections in children who were undergoing induction therapy for acute lymphoblastic leukemia (ALL).
Tian Zhang +6 more
doaj +1 more source
Posaconazole‐induced hypertension in children with cystic fibrosis
Posaconazole is a triazole antifungal with a broad spectrum of activity against moulds including Aspergillus spp. Emerging data suggest posaconazole may be effective in the treatment of allergic bronchopulmonary aspergillosis (ABPA) complicating cystic ...
Rachael Marpole +2 more
doaj +1 more source
Candida auris is a potential multidrug-resistant pathogen able to cause biofilm-associated outbreaks, where frequently indwelling devices are the source of infections.
Noémi Balla +9 more
doaj +1 more source
CAQ Corner: Basic concepts of transplant immunology
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley +1 more source
Impact of glucuronide interferences on therapeutic drug monitoring of posaconazole by tandem mass spectrometry [PDF]
Background: Posaconazole is a novel antifungal drug for oral application intended especially for therapy of invasive mycoses. Due to variable gastrointestinal absorption, adverse side effects, and suspected drug-drug interactions, therapeutic drug ...
Michael Vogeser +9 more
core +1 more source
Comparison of clinical pharmacology of voriconazole and posaconazole [PDF]
Despite greater knowledge and possibilities in pharmacotherapy, fungal infections remain a challenge for clinicians. As the population of immunocompromised patients and those treated for their hematologic ailments increases, the number of fungal ...
Anna Wiela-Hojeńska +3 more
core +1 more source
Pharmacokinetics and Pharmacodynamics of Posaconazole [PDF]
Contains fulltext : 220128.pdf (Publisher’s version ) (Open Access)Posaconazole is typically used for preventing invasive yeast and mold infections such as invasive aspergillosis in high-risk immunocompromised patients.
Krekels, E.H.J. +11 more
core +1 more source
Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism [PDF]
Posaconazole tablets are well tolerated and efficacious in the prophylaxis and treatment of aspergillosis, mucormycosis, and other invasive fungal infections.
Wittenberg, Rebecca +28 more
core +1 more source

